Cargando…

The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients

BACKGROUND: Sepsis complication is a major cause of death in multiple trauma critically ill patients. Defensin (cysteine rich anti-microbial peptides), as an important component of immune system, might play an important role in this process. There is also rising data on immunological effects of N-ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Atabak, Mojtahedzadeh, Mojtaba, Ahmadi, Keyvan Haji, Abdollahi, Mohammad, Mousavi, Maryam, Chelkeba, Legese, Najmeddin, Farhad, Ahmadi, Arezoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223415/
https://www.ncbi.nlm.nih.gov/pubmed/25027749
http://dx.doi.org/10.1186/2008-2231-22-57
_version_ 1782343194072055808
author Najafi, Atabak
Mojtahedzadeh, Mojtaba
Ahmadi, Keyvan Haji
Abdollahi, Mohammad
Mousavi, Maryam
Chelkeba, Legese
Najmeddin, Farhad
Ahmadi, Arezoo
author_facet Najafi, Atabak
Mojtahedzadeh, Mojtaba
Ahmadi, Keyvan Haji
Abdollahi, Mohammad
Mousavi, Maryam
Chelkeba, Legese
Najmeddin, Farhad
Ahmadi, Arezoo
author_sort Najafi, Atabak
collection PubMed
description BACKGROUND: Sepsis complication is a major cause of death in multiple trauma critically ill patients. Defensin (cysteine rich anti-microbial peptides), as an important component of immune system, might play an important role in this process. There is also rising data on immunological effects of N-acetyl-cysteine (NAC), a commonly used anti-oxidant in oxidative stress conditions and glutathione (GSH) deficiencies. The aim of the present study was to evaluate the potential beneficial effects of NAC administration on multiple trauma patients with sepsis. METHODS: In a prospective, randomized controlled study, 44 multiple trauma critically ill patients who were mechanically ventilated and met the criteria of sepsis and admitted to the intensive care unit (ICU) were randomized into two groups . Control group received all standard ICU therapies and NAC group received intravenous NAC 3 gr every 6 hours for 72 hours in addition to standard therapies. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores, length of ICU stay, ICU mortality were recorded. Levels of serum Immunoglobulin M (IgM), Human β-Defensin 2 (HβD2) and GSH were assessed at baseline and 24, 72, 120 hours after intervention. RESULTS: During a period of 13-month screening, 44 patients underwent randomization but 5 patients had to be excluded. 21 patients in NAC group and 18 patients in control group completed the study. For both groups the length of ICU stay, SOFA score and systemic oxygenation were similar. Mortality rate (40% vs. 22% respectively, p = 0.209) and ventilator days (Mean ± SD 19.82 ± 19.55 days vs. 13.82 ± 11.89 days respectively, p = 0.266) were slightly higher for NAC group. IgM and GSH levels were similar between two groups (p = 0.325, 0.125 respectively), HβD2 levels were higher for NAC group (at day 3). CONCLUSION: High dose of NAC administration not only did not improve patients’ outcome, but also raised the risk of inflammation and was associated with increased serum creatinine.
format Online
Article
Text
id pubmed-4223415
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42234152014-11-08 The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients Najafi, Atabak Mojtahedzadeh, Mojtaba Ahmadi, Keyvan Haji Abdollahi, Mohammad Mousavi, Maryam Chelkeba, Legese Najmeddin, Farhad Ahmadi, Arezoo Daru Research Article BACKGROUND: Sepsis complication is a major cause of death in multiple trauma critically ill patients. Defensin (cysteine rich anti-microbial peptides), as an important component of immune system, might play an important role in this process. There is also rising data on immunological effects of N-acetyl-cysteine (NAC), a commonly used anti-oxidant in oxidative stress conditions and glutathione (GSH) deficiencies. The aim of the present study was to evaluate the potential beneficial effects of NAC administration on multiple trauma patients with sepsis. METHODS: In a prospective, randomized controlled study, 44 multiple trauma critically ill patients who were mechanically ventilated and met the criteria of sepsis and admitted to the intensive care unit (ICU) were randomized into two groups . Control group received all standard ICU therapies and NAC group received intravenous NAC 3 gr every 6 hours for 72 hours in addition to standard therapies. Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores, length of ICU stay, ICU mortality were recorded. Levels of serum Immunoglobulin M (IgM), Human β-Defensin 2 (HβD2) and GSH were assessed at baseline and 24, 72, 120 hours after intervention. RESULTS: During a period of 13-month screening, 44 patients underwent randomization but 5 patients had to be excluded. 21 patients in NAC group and 18 patients in control group completed the study. For both groups the length of ICU stay, SOFA score and systemic oxygenation were similar. Mortality rate (40% vs. 22% respectively, p = 0.209) and ventilator days (Mean ± SD 19.82 ± 19.55 days vs. 13.82 ± 11.89 days respectively, p = 0.266) were slightly higher for NAC group. IgM and GSH levels were similar between two groups (p = 0.325, 0.125 respectively), HβD2 levels were higher for NAC group (at day 3). CONCLUSION: High dose of NAC administration not only did not improve patients’ outcome, but also raised the risk of inflammation and was associated with increased serum creatinine. BioMed Central 2014-07-15 /pmc/articles/PMC4223415/ /pubmed/25027749 http://dx.doi.org/10.1186/2008-2231-22-57 Text en Copyright © 2014 Mojtahedzadeh et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Najafi, Atabak
Mojtahedzadeh, Mojtaba
Ahmadi, Keyvan Haji
Abdollahi, Mohammad
Mousavi, Maryam
Chelkeba, Legese
Najmeddin, Farhad
Ahmadi, Arezoo
The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
title The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
title_full The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
title_fullStr The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
title_full_unstemmed The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
title_short The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients
title_sort immunological benefit of higher dose n-acetyl cysteine following mechanical ventilation in critically ill patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223415/
https://www.ncbi.nlm.nih.gov/pubmed/25027749
http://dx.doi.org/10.1186/2008-2231-22-57
work_keys_str_mv AT najafiatabak theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT mojtahedzadehmojtaba theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT ahmadikeyvanhaji theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT abdollahimohammad theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT mousavimaryam theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT chelkebalegese theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT najmeddinfarhad theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT ahmadiarezoo theimmunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT najafiatabak immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT mojtahedzadehmojtaba immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT ahmadikeyvanhaji immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT abdollahimohammad immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT mousavimaryam immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT chelkebalegese immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT najmeddinfarhad immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients
AT ahmadiarezoo immunologicalbenefitofhigherdosenacetylcysteinefollowingmechanicalventilationincriticallyillpatients